1)- Shuchi Agrawal-Singh, Jaana Bagri, Nathalie Sakakini, Brian J P Huntly. A guide to epigenetics in leukaemia stem cells.Molecular oncology. 2023, 17 (12): 2493-2506
3)- Richard Bayliss, Elżbieta Sarnowska, Sharon Yeoh, Josephina Sampson. ALKing the flames of lung cancer immunosensitivity.Molecular oncology. 2023, 17 (11): 2218-2220
5)- Mark T Burgess, Jill Gluskin, Katja Pinker. From bedside to portable and wearable: development of a conformable ultrasound patch for deep breast tissue imaging.Molecular oncology. 2023, 17 (10): 1947-1949
8)- Nayela N Chowdhury, Yi Yang, Ananya Dutta, Michelle Luo, Zimu Wei, Sara R Abrahams, Alexey S Revenko, Fenil Shah, Lindsey A Miles, Robert J Parmer, Bas de Laat, Alisa S Wolberg, James P Luyendyk, Melissa L Fishel, Matthew J Flick. Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression.Molecular oncology. 2023, :
10)- Sara Hijazo-Pechero, Ania Alay, David Cordero, Raúl Marín, Noelia Vilariño, Ramón Palmero, Jesús Brenes, Aina Montalban-Casafont, Ernest Nadal, Xavier Solé. Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications.Molecular oncology. 2023, :
11)- Maike Pohlers, Selina Gies, Tanja Taenzer, Russalina Stroeder, Laura Theobald, Nicole Ludwig, Yoo-Jin Kim, Rainer Maria Bohle, Erich Franz Solomayer, Eckart Meese, Martin Hart, Barbara Walch-Rückheim. Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers.Molecular oncology. 2023, :
13)- Zhe Yu, Zirui Zhang, Jun Liu, Xiaoying Wu, Xiaojun Fan, Jiaohui Pang, Hua Bao, Jiani Yin, Xue Wu, Yang Shao, Zhengcheng Liu, Fang Liu. Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing.Molecular oncology. 2023, :
14)- Denis Belitškin, Pauliina Munne, Shishir M Pant, Johanna M Anttila, Ilida Suleymanova, Kati Belitškina, Daniel Kirchhofer, James Janetka, Taivo Käsper, Sami Jalil, Jeroen Pouwels, Topi A Tervonen, Juha Klefström. Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axis.Molecular oncology. 2023, :
16)- Joseph S Baxter, Rachel Brough, Dragomir B Krastev, Feifei Song, Sandhya Sridhar, Aditi Gulati, John Alexander, Theodoros I Roumeliotis, Zuza Kozik, Jyoti S Choudhary, Syed Haider, Stephen J Pettitt, Andrew N J Tutt, Christopher J Lord. Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.Molecular oncology. 2023, :
17)- Marion Morel, Weiwen Long. FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling.Molecular oncology. 2023, :
18)- Dong Hyun Lee, Muhammad Imran, Jae Ho Choi, Yoo Jung Park, Young Hwa Kim, Sunwoo Min, Tae Jun Park, Yong Won Choi. CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents.Molecular oncology. 2023, :
19)- Isabel Mayayo-Peralta, Donna O Debets, Stefan Prekovic, Karianne Schuurman, Suzanne Beerthuijzen, Mathilde Almekinders, Joyce Sanders, Cathy B Moelans, Sandra Saleiro, Jelle Wesseling, Paul J van Diest, Rui Henrique, Carmen Jerónimo, Maarten Altelaar, Wilbert Zwart. Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation.Molecular oncology. 2023, :
20)- Sara Bønløkke, Torben Steiniche, Boe Sandahl Sorensen, Gitte-Bettina Nyvang, Jacob Christian Lindegaard, Jan Blaakaer, Jesper Bertelsen, Katrine Fuglsang, Mikael Lenz Strube, Suzan Lenz, Magnus Stougaard. Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.Molecular oncology. 2023, :
21)- Xue Yang, Zexuan Liu, Weiwei Tang, Uday P Pratap, Alexia B Collier, Kristin A Altwegg, Rahul Gopalam, Xiaonan Li, Yaxia Yuan, Daohong Zhou, Zhao Lai, Yidong Chen, Gangadhara R Sareddy, Philip T Valente, Edward R Kost, Suryavathi Viswanadhapalli, Ratna K Vadlamudi. PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.Molecular oncology. 2023, :
22)- Arun Everest-Dass, Stepan Nersisyan, Hanna Maar, Victor Novosad, Jennifer Schröder-Schwarz, Vera Freytag, Johanna L Stuke, Mia C Beine, Alina Schiecke, Marie-Therese Haider, Malte Kriegs, Omar Elakad, Hanibal Bohnenberger, Lena-Christin Conradi, Maria Raygorodskaya, Linda Krause, Mark von Itzstein, Alexander Tonevitsky, Udo Schumacher, Diana Maltseva, Daniel Wicklein, Tobias Lange. Spontaneous metastasis xenograft models link CD44 isoform 4 to angiogenesis, hypoxia, EMT and mitochondria-related pathways in colorectal cancer.Molecular oncology. 2023, :
23)- Yao-Yu Hsieh, Jia-Ling Du, Pei-Ming Yang. Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance.Molecular oncology. 2023, :
24)- Edgar Creus-Bachiller, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz, Sara Ortega-Bertran, Susana Navas-Rutete, Cleofe Romagosa, Tulio M Silva, Maria Pané, Anna Estival, Diana Perez Sidelnikova, Mireia Morell, Helena Mazuelas, Meritxell Carrió, Tereza Lausová, David Reuss, Bernat Gel, Alberto Villanueva, Eduard Serra, Conxi Lázaro. Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.Molecular oncology. 2023, :
25)- Alamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, Hannah F Cahill, Marie-Claire D Wasson, Raj Pranap Arun, Olivia L Walker, Brianne M Cruickshank, Wasundara Fernando, Jaganathan Venkatesh, Penelope J Barnes, Gillian Bethune, Gregory Knapp, Lucy K Helyer, Carman A Giacomantonio, David M Waisman, Paola Marcato. ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.Molecular oncology. 2023, :
26)- Angélica Martínez-López, Ana García-Casas, Guiomar Infante, Mónica González-Fernández, Nélida Salvador, Mar Lorente, Marina Mendiburu-Eliçabe, Santiago Gonzalez-Moreno, Pedro Villarejo-Campos, Guillermo Velasco, Angeliki Malliri, Sonia Castillo-Lluva. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.Molecular oncology. 2023, :
27)- Christina Bligaard Pedersen, Benito Campos, Lasse Rene, Helene Scheel Wegener, Neeraja M Krishnan, Binay Panda, Kristoffer Vitting-Seerup, Maria Rossing, Frederik Otzen Bagger, Lars Rønn Olsen. Building flexible and robust analysis frameworks for molecular subtyping of cancers.Molecular oncology. 2023, :
31)- Ulrik Ringborg, Joachim von Braun, Julio Celis, Michael Baumann, Anton Berns, Alexander Eggermont, Edith Heard, Manuel Heitor, Mammen Chandy, Chien-Jen Chen, Alberto Costa, Francesco De Lorenzo, Edward M De Robertis, Frederick Charles Dubee, Ingemar Ernberg, Mariya Gabriel, Åslaug Helland, Rui Henrique, Bengt Jönsson, Olli Kallioniemi, Jan Korbel, Mechthild Krause, Douglas R Lowy, Olivier Michielin, Peter Nagy, Simon Oberst, Vincenzo Paglia, M Iqbal Parker, Kevin Ryan, Charles L Sawyers, Joachim. Strategies to decrease inequalities in cancer therapeutics, care and prevention.Molecular oncology. 2023, :
32)- María Gallardo-Gómez, Lara Costas-Ríos, Carlos A Garcia-Prieto, Lara Álvarez-Rodríguez, Luis Bujanda, Maialen Barrero, Antoni Castells, Francesc Balaguer, Rodrigo Jover, Manel Esteller, Antoni Tardío Baiges, Joaquín González-Carreró Fojón, Joaquín Cubiella, Loretta De Chiara. Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection.Molecular oncology. 2023, :
33)- Chloe Gulliver, Tara Busiau, Ashleigh Byrne, Jane E Findlay, Ralf Hoffmann, George S Baillie. cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.Molecular oncology. 2023, :
34)- Helga Simon-Molas, Rosita Del Prete, Anna Kabanova. Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways.Molecular oncology. 2023, :
35)- Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann. Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.Molecular oncology. 2023, :
36)- Laura Zarzuela, Raúl V Durán, Mercedes Tomé. Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance.Molecular oncology. 2023, :
37)- Sivahari Prasad Gorantla, Tony Andreas Mueller, Corinna Albers-Leischner, Martina Rudelius, Nikolas von Bubnoff, Justus Duyster. A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance.Molecular oncology. 2023, :
38)- Daniela Schulz, Laura Feulner, Dominique Santos Rubenich, Sina Heimer, Sophia Rohrmüller, Yvonne Reinders, Marcelo Falchetti, Martin Wetzel, Elizandra Braganhol, Edroaldo Lummertz da Rocha, Nicole Schäfer, Sabine Stöckl, Gero Brockhoff, Anja K Wege, Jürgen Fritsch, Fabian Pohl, Torsten E Reichert, Tobias Ettl, Richard J Bauer. Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy.Molecular oncology. 2023, :
39)- Javier A Menendez, Elisabet Cuyàs, Jose Antonio Encinar, Travis Vander Steen, Sara Verdura, Àngela Llop-Hernández, Júlia López, Eila Serrano-Hervás, Sílvia Osuna, Begoña Martin-Castillo, Ruth Lupu. The Fatty Acid Synthase (FASN) signalome: A molecular guide for precision oncology.Molecular oncology. 2023, :
40)- Michiel Stevens, Anouk Mentink, Frank Aw Coumans, Eshwari Dathathri, Khrystany T Isebia, Jaco Kraan, Ronald de Wit, John Wm Martens, Leon Wmm Terstappen. Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.Molecular oncology. 2023, :
41)- Patricia L Theard, Amanda J Linke, Nancy E Sealover, Brianna R Daley, Johnny Yang, Katherine Cox, Robert L Kortum. SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.Molecular oncology. 2023, :
42)- Astrid Kramer, Carmen Rubio-Alarcón, Daan van den Broek, Daan C L Vessies, Iris van T Erve, Gerrit A Meijer, Geraldine R Vink, Ed Schuuring, Remond J A Fijneman, Veerle M H Coupé, Valesca P Retèl. A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.Molecular oncology. 2023, :
43)- Jianfeng He, Caihu Huang, Yanmin Guo, Rong Deng, Lian Li, Ran Chen, Yanli Wang, Jian Huang, Junke Zheng, Xian Zhao, Jianxiu Yu. PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.Molecular oncology. 2023, :
44)- Selas T F Bots, Tom J Harryvan, Christianne Groeneveldt, Priscilla Kinderman, Vera Kemp, Nadine van Montfoort, Rob C Hoeben. Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.Molecular oncology. 2023, :
45)- Ekaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, Antony Tin, Shifra Krinshpun, Raheleh Salari, Carly Bess Scalise, Rosalyn Ram, Meenakshi Malhotra, Harini Ravi, Himanshu Sethi, Stephanie Sanchez, Robert Tanner Hagelstrom, Maxim Brevnov, Matthew Rabinowitz, Solomon Moshkevich, Bernhard G Zimmermann, Minetta C Liu, Alexey Aleshin. Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.Molecular oncology. 2023, :
48)- Franziska Böttger, Teodora Radonic, Idris Bahce, Kim Monkhorst, Sander R Piersma, Thang V Pham, Anne-Marie C Dingemans, Lisa M Hillen, Mariacarmela Santarpia, Elisa Giovannetti, Egbert F Smit, Sjaak A Burgers, Connie R Jimenez. Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.Molecular oncology. 2023, :
49)- Núria Gendrau-Sanclemente, Agnès Figueras, Kristina Gracova, Álvaro Lahiguera, Elisenda Alsina-Sanchís, Juan A Marín-Jiménez, August Vidal, Xavier Matias-Guiu, Sergi Fernandez-Gonzalez, Marc Barahona, Lola Martí, Jordi Ponce, Francesc Viñals. Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.Molecular oncology. 2023, :
50)- Malay K Sannigrahi, Austin C Cao, Pavithra Rajagopalan, Lova Sun, Robert M Brody, Lovely Raghav, Phyllis A Gimotty, Devraj Basu. A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas.Molecular oncology. 2023, :